Nonetheless, pretreatment with TQ, a PPAR-γ agonist, counteracted the effect of SCOP, which could explain its beneficial role against SCOP-induced neuronal injury and cognitive impairment. The gene discussed is PPARG; the disease is Cognitive impairment.